Walleye Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Walleye Trading’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-571	Closed	-$90K	–	4930
2018 Q4	$90K	Hold	571	–	–	﹤0.01%	3935
2018 Q3	$140K	Sell	571 -673	-54%	-$159K	﹤0.01%	4009
2018 Q2	$279K	Hold	1,244	–	–	﹤0.01%	3349
2018 Q1	$305K	Sell	1,244 -86	-6%	-$22.6K	﹤0.01%	3119
2017 Q4	$410K	Buy	+1,330	New	+$438K	﹤0.01%	2793
2016 Q4	–	Sell	-3,666	Closed	-$880K	–	5306
2016 Q3	$880K	Sell	3,666 -264	-7%	-$54.9K	0.01%	1656
2016 Q2	$770K	Buy	3,930 +2,128	+118%	+$981K	0.01%	1831
2016 Q1	$773K	Buy	1,802 +29	+2%	+$10.4K	0.01%	1623
2015 Q4	$670K	Buy	1,773 +275	+18%	+$86.2K	0.01%	1601
2015 Q3	$406K	Buy	1,498 +141	+10%	+$39.3K	﹤0.01%	1714
2015 Q2	$399K	Buy	+1,357	New	+$410K	﹤0.01%	1851

Other funds holding DMK

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Walleye Trading's DMK Position: Q1 2019 in Review

Walleye Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2019, closing a stake of 571 shares — an estimated $90K sold.

Walleye Trading first reported a position in DMK in Q2 2015 and held it in 11 quarters. The position peaked at $880K in Q3 2016. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

Walleye Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2019 after selling out during the quarter.
Walleye Trading sold 571 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2019, an estimated $90K.
Walleye Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2015 and held it in 11 quarters.
Walleye Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $880K in Q3 2016.
57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2019.

Based on Walleye Trading's 13F filing for Q1 2019, filed 15 May 2019.